Skip to main navigation Skip to search Skip to main content

Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

  • Ellen M. Apperloo
  • , Brendon L. Neuen
  • , Robert A. Fletcher
  • , Niels Jongs
  • , Stefan D. Anker
  • , Deepak L. Bhatt
  • , Javed Butler
  • , David Z.I. Cherney
  • , William G. Herrington
  • , Silvio E. Inzucchi
  • , Meg J. Jardine
  • , Chih Chin Liu
  • , Kenneth W. Mahaffey
  • , Darren K. McGuire
  • , John J.V. McMurray
  • , Bruce Neal
  • , Milton Packer
  • , Vlado Perkovic
  • , Marc S. Sabatine
  • , Scott D. Solomon
    • Natalie Staplin, Michael Szarek, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Stephen D. Wiviott, Faiez Zannad, Hiddo J.L. Heerspink

Research output: Contribution to journal › Article › peer-review

116 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science